Sentence examples for biologic to from inspiring English sources

It is therefore imperative to consider the type of biologic to be delivered, the method of delivery, and the temporal as well as spatial presentation of the biologic to achieve the desired effect in cartilage repair.

These changes allow the modified biologic to have considerable enhancements that include, but are not limited to, increased half-life, reduced toxicity, reduced immunogenicity, and enhanced pharmacodynamic effects.

While the ultimate outcome desired may vary significantly (preservation vs. ablation) the overall response of a biologic to low temperature exposure share a number of commonalities, as well as differences, at the molecular level.

The company, founded in 1978 by Kiran Mazumdar-Shaw, began setting up its first overseas manufacturing facility in Malaysia in 2011, and recently launched the world's first humanized anti-epidermal growth factor receptor (EGFR) monoclonal antibody, nimotuzumab, which is also the first novel biologic to be developed in India.

States must also ensure that physicians and pharmacists are notified if a patient is switched from the innovator biologic to its biosimilar.

Congress is trying to iron out legislation that enables biologic medications that are intended to "copy" a previously approved biologic to get to market, in the same manner as generic drugs now compete with brand drugs when patents expire.

Hatch accused Australia of wanting biologics to come off patent as quickly as possible.

The Australian trade minister Andrew Robb says 40 straight hours of negotiation were required at the final meeting to settle the treatment of biologics to Canberra's satisfaction.

But in April, the Biotechnology Industry Organization, a trade group based in Washington, petitioned the F.D.A. to withdraw draft rules that would have allowed comparable biologics to be eligible for approval.

One reason for limited savings in the first decade is that it would probably take a few years for copycat biologics to reach the market after the law was enacted.

"We have wonderful new drugs, the biologics, to treat rheumatoid arthritis, but they are extremely expensive," said Dr. Patience H. White, a vice president of the Arthritis Foundation.